ISRCTN31248612
Active, not recruiting
未知
Exploring the impact and underlying mechanisms of arachidonic acid supplementation on cognitive impairment in schizophrenia: a double-blinded, placebo-controlled, randomized study
ational Natural Science Foundation of China0 sites62 target enrollmentJuly 5, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Schizophrenia
- Sponsor
- ational Natural Science Foundation of China
- Enrollment
- 62
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients of SZ were diagnosed according to the International Classification of Diseases 10th edition (ICD\-10\)
- •2\. The patient's family members or legal guardians fully understood the content of this study and signed informed consent
Exclusion Criteria
- •1\. Patients should not have a history of other mental disorders, neurological disorders, serious physical diseases, traumatic brain injury, substance abuse, or dependence
- •2\. Healthy controls should not have any current or previous psychiatric history or family history, as assessed by the Mini\-International Neuropsychiatric Interview (M.I.N.I.)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
An investigation into the mechanisms of action of a combined long acting beta agonist/inhaled corticosteroid (Seretide 500 accuhaler) on the bacterial colonisation, immunology and inflammation of patients with Chronic Obstructive Pulmonary Disease (COPD)EUCTR2009-015876-86-GBSouthampton University Hospitals
Not yet recruiting
Not Applicable
Grief after MH17 Plane CrashPersistent Complex Bereavement Disorder, Cognitive Behavioral Therapy, Eye Movement Desensitization and ReprocessingNL-OMON231051. University of Groningen2. Utrecht University 4. Foundation Centrum ’45 Arq Psychotrauma Expert Group113
Recruiting
Not Applicable
Study of investigating the mechanism of action of azacitidine in patients with myelodysplastic syndrome/acute myeloid leukemia with myelodysplasia-related changes by single cell RNA sequencemyelodysplastic syndrome,acute myeloid leukemia with myelodysplasia-related changesJPRN-UMIN000042515The University of Tokyo17
Recruiting
Phase 1
DapaBalci-LeapStage 3 chronic kidney diseaseMedDRA version: 20.0Level: SOCClassification code: 10038359Term: Renal and urinary disorders Class: 18Therapeutic area: Diseases [C] - Male Urogenital Diseases [C12]CTIS2024-516032-10-00Winicker-Norimed Medizinische Forschung GmbH150
Completed
Not Applicable
Revealing mechanisms and investigating efficacy of hemoadsorption for prevention of vasodilatory shock in cardiac surgery patients with infective endocarditis – a multicentric randomized controlled group sequential trialI33.0Acute and subacute infective endocarditisDRKS00013740Center for Sepsis Control & Care Universitätsklinikum Jena288